APA (7th ed.) Citation

Bräutigam, J., Bischoff, I., Schürmann, C., Buchmann, G., Epah, J., Fuchs, S., . . . Fürst, R. (2019). Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Journal of Molecular & Cellular Cardiology, 135, 97. https://doi.org/10.1016/j.yjmcc.2019.08.001

Chicago Style (17th ed.) Citation

Bräutigam, Jacqueline, Iris Bischoff, Christoph Schürmann, Giulia Buchmann, Jeremy Epah, Simone Fuchs, Elke Heiss, Ralf P. Brandes, and Robert Fürst. "Narciclasine Inhibits Angiogenic Processes by Activation of Rho Kinase and by Downregulation of the VEGF Receptor 2." Journal of Molecular & Cellular Cardiology 135 (2019): 97. https://doi.org/10.1016/j.yjmcc.2019.08.001.

MLA (9th ed.) Citation

Bräutigam, Jacqueline, et al. "Narciclasine Inhibits Angiogenic Processes by Activation of Rho Kinase and by Downregulation of the VEGF Receptor 2." Journal of Molecular & Cellular Cardiology, vol. 135, 2019, p. 97, https://doi.org/10.1016/j.yjmcc.2019.08.001.